Hyaluronic acid-based gels including lidocaine

Patent metadata

Field	Value
Publication number	US-9238013-B2
Application number	US-201313746170-A
Country	US
Kind code	B2
Filing date	Jan 21, 2013
Priority date	Aug 4, 2008
Publication date	Jan 19, 2016
Grant date	Jan 19, 2016

Abstract

Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability and cohesivity, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.

First claim

What is claimed is:

1. A dermal filler comprising:
(a) a mixture comprising particles of hyaluronic acid crosslinked with 1,4-butanediol diglycidyl ether, and free hyaluronic acid;
(b) about 0.3% by weight lidocaine combined with the mixture;
wherein the dermal filler is heat sterile and has a pH of about 7.

2. The dermal filler of claim 1 wherein the dermal filler requires an extrusion force of between about 10N and about 13N when injected at a rate of about 12.5 mm/minute.

3. The dermal filler of claim 1 wherein the dermal filler has a viscosity of between about 5 Pa*s and about 450 Pa*s when measured at about 5 Hz.

4. A dermal filler comprising:
(a) a hyaluronic acid including particles of crosslinked hyaluronic acid mixed with free hyaluronic acid; and
(b) about 0.3% by weight lidocaine mixed with the hyaluronic acid, wherein:
the crosslinked hyaluronic acid is crosslinked with 1,4-butanediol diglycidyl ether;
the dermal filler being stable at about 25° C. for at least about 6 months after heat sterilization at a temperature of about at least about 120° C. to about 130° C. for a period of at least about 1 minute to about 15 minutes;
the dermal filler having a pH of about 7;
the dermal filler requiring an extrusion force of between about 10N and about 13N when injected at a rate of about 12.5 mm/minute; and
the dermal filler having a viscosity of between about 5 Pa*s and about 450 Pa*s when measured at about 5 Hz.

Assignees

• Allergan Ind Sas

Inventors

• Lebreton Pierre

Classifications

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61P23/02

  Local anaesthetics · CPC title

• A61P23/00

  Anaesthetics · CPC title

• A61L2103/05

  Living organisms or biological materials · CPC title